RPS-BLAST 2.2.26 [Sep-21-2011]
Database: CDD.v3.10
44,354 sequences; 10,937,602 total letters
Searching..................................................done
Query= psy12302
(303 letters)
>gnl|CDD|240417 PTZ00435, PTZ00435, isocitrate dehydrogenase; Provisional.
Length = 413
Score = 325 bits (834), Expect = e-110
Identities = 116/163 (71%), Positives = 130/163 (79%), Gaps = 1/163 (0%)
Query: 137 IDVECLYYDLGLPHRDATEDQVTVDAAVAIKKHNVGIKCATITPDEARVKEFKLKKMWLS 196
+DV YYDL + +RD T+D+VTVDAA AIKKH VGIKCATITPDEARVKEF LKKMW S
Sbjct: 37 LDVPIKYYDLSIENRDKTDDKVTVDAAEAIKKHKVGIKCATITPDEARVKEFNLKKMWKS 96
Query: 197 PNGTIRNILGGTVFREPIICKNIPKIVPGWTNSIVIGRHAHGDQYKATDLIVDKPGKVEL 256
PNGTIRNIL GTVFREPII KNIP++VPGW IVIGRHA GDQYKATD +VD PGK+EL
Sbjct: 97 PNGTIRNILDGTVFREPIIIKNIPRLVPGWKKPIVIGRHAFGDQYKATDFVVDGPGKLEL 156
Query: 257 VYT-DNQGKVQTFKVFEFKTPGVALAMYNTTESIESFAHSSFQ 298
V+T + + Q VF+FK GVA+ MYNT ESIE FA S FQ
Sbjct: 157 VFTPADGSEPQRVDVFDFKGGGVAMGMYNTDESIEGFARSCFQ 199
Score = 77.3 bits (191), Expect = 6e-16
Identities = 27/38 (71%), Positives = 31/38 (81%)
Query: 33 TDSRIVAKNPVVEMDGDEMTRIIWENIKEKLIFPYVKV 70
T +I KNPVVE+DGDEMTRIIW+ IKEKLI PY+ V
Sbjct: 2 TGGKIKVKNPVVELDGDEMTRIIWKMIKEKLILPYLDV 39
>gnl|CDD|236226 PRK08299, PRK08299, isocitrate dehydrogenase; Validated.
Length = 402
Score = 318 bits (818), Expect = e-108
Identities = 108/162 (66%), Positives = 129/162 (79%)
Query: 137 IDVECLYYDLGLPHRDATEDQVTVDAAVAIKKHNVGIKCATITPDEARVKEFKLKKMWLS 196
+D++ YYDLG+ +RDAT+DQVT+DAA AIKK+ VG+KCATITPDEARVKEF LKKMW S
Sbjct: 35 LDIDLEYYDLGIENRDATDDQVTIDAANAIKKYGVGVKCATITPDEARVKEFNLKKMWKS 94
Query: 197 PNGTIRNILGGTVFREPIICKNIPKIVPGWTNSIVIGRHAHGDQYKATDLIVDKPGKVEL 256
PNGTIRNILGGTVFREPIICKN+P++VPGWT IVIGRHA+GDQY+ATD V GK+ L
Sbjct: 95 PNGTIRNILGGTVFREPIICKNVPRLVPGWTKPIVIGRHAYGDQYRATDFKVPGKGKLTL 154
Query: 257 VYTDNQGKVQTFKVFEFKTPGVALAMYNTTESIESFAHSSFQ 298
V+T G+ +V +F GVA+ MYN ESI FA +SF
Sbjct: 155 VFTGEDGEPIEHEVHDFPGAGVAMGMYNLDESIRDFARASFN 196
Score = 73.0 bits (180), Expect = 1e-14
Identities = 24/36 (66%), Positives = 31/36 (86%)
Query: 35 SRIVAKNPVVEMDGDEMTRIIWENIKEKLIFPYVKV 70
++I KNPVVE+DGDEMTRIIW+ IK+KLI PY+ +
Sbjct: 2 AKIKVKNPVVELDGDEMTRIIWKFIKDKLILPYLDI 37
>gnl|CDD|129233 TIGR00127, nadp_idh_euk, isocitrate dehydrogenase, NADP-dependent,
eukaryotic type. This model describes a eukaryotic,
NADP-dependent form of isocitrate dehydrogenase. These
eukaryotic enzymes differ considerably from a fairly
tight cluster that includes all other related isocitrate
dehydrogenases, 3-isopropylmalate dehydrogenases, and
tartrate dehydrogenases. Several NAD- or NADP-dependent
dehydrogenases, including 3-isopropylmalate
dehydrogenase, tartrate dehydrogenase, and the
multimeric forms of isocitrate dehydrogenase, share a
nucleotide binding domain unrelated to that of lactate
dehydrogenase and its homologs. These enzymes
dehydrogenate their substates at a H-C-OH site adjacent
to a H-C-COOH site; the latter carbon, now adjacent to a
carbonyl group, readily decarboxylates. This model does
not discriminate cytosolic, mitochondrial, and
chloroplast proteins. However, the model starts very
near the amino end of the cytosolic form; the finding of
additional amino-terminal sequence may indicate a
transit peptide [Energy metabolism, TCA cycle].
Length = 409
Score = 279 bits (715), Expect = 2e-92
Identities = 134/268 (50%), Positives = 162/268 (60%), Gaps = 71/268 (26%)
Query: 35 SRIVAKNPVVEMDGDEMTRIIWENIKEKLIFPYVKVCMSIIIFNKFQAFLLFPEKSEEMN 94
S+I NPVVEMDGDE M+ II+ + L+ P
Sbjct: 1 SKIKVANPVVEMDGDE---------------------MTRIIWELIKDKLILP------- 32
Query: 95 LEWIKIPCLQCSDKAKMFFLSSSLKHGFMYFMASRIQIISNIIDVECLYYDLGLPHRDAT 154
++++ YYDLG+ +RDAT
Sbjct: 33 -----------------------------------------YVELDLKYYDLGVEYRDAT 51
Query: 155 EDQVTVDAAVAIKKHNVGIKCATITPDEARVKEFKLKKMWLSPNGTIRNILGGTVFREPI 214
DQVTVDAA AIKK+NVG+KCATITPDEARV+EFKLKKMW SPNGTIRNILGGTVFREPI
Sbjct: 52 NDQVTVDAAEAIKKYNVGVKCATITPDEARVEEFKLKKMWKSPNGTIRNILGGTVFREPI 111
Query: 215 ICKNIPKIVPGWTNSIVIGRHAHGDQYKATDLIVDKPGKVELVYT-DNQGKVQTFKVFEF 273
ICKNIP++VPGW I+IGRHA GDQY+ATD +V PGK+ELVY + + T KV++F
Sbjct: 112 ICKNIPRLVPGWEKPIIIGRHAFGDQYRATDFVVPGPGKLELVYKPKDGTQKVTLKVYDF 171
Query: 274 KTPG-VALAMYNTTESIESFAHSSFQVS 300
+ G VA+AMYNT ESIE FAHSSFQ++
Sbjct: 172 EEGGGVAMAMYNTDESIEGFAHSSFQLA 199
>gnl|CDD|178617 PLN03065, PLN03065, isocitrate dehydrogenase (NADP+); Provisional.
Length = 483
Score = 277 bits (711), Expect = 8e-91
Identities = 102/172 (59%), Positives = 132/172 (76%), Gaps = 1/172 (0%)
Query: 131 QIISNIIDVECLYYDLGLPHRDATEDQVTVDAAVAIKKHNVGIKCATITPDEARVKEFKL 190
++I +D++ Y+DLG+ +RDAT+D+VTV++A A K+NV IKCATITPDEARVKEF L
Sbjct: 99 KLIFPYLDLDIKYFDLGILNRDATDDKVTVESAEATLKYNVAIKCATITPDEARVKEFGL 158
Query: 191 KKMWLSPNGTIRNILGGTVFREPIICKNIPKIVPGWTNSIVIGRHAHGDQYKATDLIVDK 250
K MW SPNGTIRNIL GTVFREPI+CKNIP++VPGW I IGRHA GDQY+ATD ++
Sbjct: 159 KSMWRSPNGTIRNILNGTVFREPILCKNIPRLVPGWKKPICIGRHAFGDQYRATDTVIKG 218
Query: 251 PGKVELVYT-DNQGKVQTFKVFEFKTPGVALAMYNTTESIESFAHSSFQVSF 301
PGK+++V+ ++ V++FK PGVALAMYN ESI +FA SS ++
Sbjct: 219 PGKLKMVFVPEDGNAPVELDVYDFKGPGVALAMYNVDESIRAFAESSMAMAL 270
Score = 68.8 bits (168), Expect = 4e-13
Identities = 25/37 (67%), Positives = 31/37 (83%)
Query: 32 ATDSRIVAKNPVVEMDGDEMTRIIWENIKEKLIFPYV 68
A RI +NP+VEMDGDEMTR+IW+ IK+KLIFPY+
Sbjct: 69 AAADRIKVQNPIVEMDGDEMTRVIWQMIKDKLIFPYL 105
>gnl|CDD|177720 PLN00103, PLN00103, isocitrate dehydrogenase (NADP+); Provisional.
Length = 410
Score = 266 bits (682), Expect = 3e-87
Identities = 104/173 (60%), Positives = 135/173 (78%), Gaps = 2/173 (1%)
Query: 131 QIISNIIDVECLYYDLGLPHRDATEDQVTVDAAVAIKKHNVGIKCATITPDEARVKEFKL 190
++I +D++ Y+DLGLP+RDAT+D+VTV++A A K+NV IKCATITPDEARVKEF L
Sbjct: 31 KLIFPFLDLDIKYFDLGLPNRDATDDKVTVESAEATLKYNVAIKCATITPDEARVKEFGL 90
Query: 191 KKMWLSPNGTIRNILGGTVFREPIICKNIPKIVPGWTNSIVIGRHAHGDQYKATDLIVDK 250
K+MW SPNGTIRNIL GTVFREPIICKNIP++VPGWT I IGRHA GDQY+ATD ++
Sbjct: 91 KQMWKSPNGTIRNILNGTVFREPIICKNIPRLVPGWTKPICIGRHAFGDQYRATDAVIKG 150
Query: 251 PGKVELVYT-DNQGKVQTFKVFEFK-TPGVALAMYNTTESIESFAHSSFQVSF 301
PGK++LV+ + + + +V+ F GVAL+MYNT ESI +FA +S ++
Sbjct: 151 PGKLKLVFVPEGKDEKTELEVYNFTGAGGVALSMYNTDESIRAFAEASMNTAY 203
Score = 66.8 bits (163), Expect = 2e-12
Identities = 22/35 (62%), Positives = 31/35 (88%)
Query: 36 RIVAKNPVVEMDGDEMTRIIWENIKEKLIFPYVKV 70
+I NP+VEMDGDEMTR+IW++IK+KLIFP++ +
Sbjct: 5 KIKVANPIVEMDGDEMTRVIWKSIKDKLIFPFLDL 39
>gnl|CDD|223612 COG0538, Icd, Isocitrate dehydrogenases [Energy production and
conversion].
Length = 407
Score = 170 bits (432), Expect = 6e-50
Identities = 43/164 (26%), Positives = 65/164 (39%), Gaps = 15/164 (9%)
Query: 138 DVECLYYDLGLPHRDATEDQVTVDAAVAIKKHNVGIKCATITPDEARVKEFKLKKMWLSP 197
+E D G RD T DQ+ ++ AIKK+ V IK TP + K W S
Sbjct: 54 KIEWKEVDAGEKARDKTGDQLPIETLEAIKKYGVAIKGPLTTP---------VGKGWRSL 104
Query: 198 NGTIRNILGGTVFREPIICK-NIPKIVPG-WTNSIVIGRHAHGDQYKATDLIVDKPGKVE 255
N T+R IL VFR P+ +P V +VI R D Y + P ++
Sbjct: 105 NVTLRQILDLYVFRRPVRYFPGVPSPVKRPEKVDMVIFRENTEDIYAGIEWKAGSPEALK 164
Query: 256 LVYTDNQGKVQTFKVFEF-KTPGVALAMYNTTESIESFAHSSFQ 298
L++ K F + G+ + + SI ++ +
Sbjct: 165 LIFFLEDEM--GVKKIRFPEDSGIGIKPISKEGSIR-LVRAAIE 205
Score = 43.8 bits (104), Expect = 6e-05
Identities = 12/30 (40%), Positives = 16/30 (53%), Gaps = 2/30 (6%)
Query: 40 KNPVVEMD--GDEMTRIIWENIKEKLIFPY 67
P +E D GDE+TR IW+ I + Y
Sbjct: 20 IIPFIEGDGIGDEITRAIWKVIDAAVEKAY 49
>gnl|CDD|215773 pfam00180, Iso_dh, Isocitrate/isopropylmalate dehydrogenase.
Length = 349
Score = 74.6 bits (184), Expect = 3e-15
Identities = 29/161 (18%), Positives = 45/161 (27%), Gaps = 29/161 (18%)
Query: 143 YYDLGLPHRDATEDQVTVDAAVAIKKHNVGIKCATITPD----EARVKEFKLKKMWLSPN 198
G D T + + A KK + + A P R + L +
Sbjct: 37 EGLAGGAAIDETGTPLPEETLEACKKADAVLLGAVGGPKWNPGGVRPENG-LLALRKEL- 94
Query: 199 GTIRNILGGTVFREPIICKNIPK-IVPGWTNSIVIGRHAHGDQYKATDLIVDKPGKVELV 257
G N+ VF + + K V + IVI R G Y +
Sbjct: 95 GLFANLRPVKVFP-SLGDASPLKREVVEGVD-IVIVRELTGGIYFGIPKGIK-------- 144
Query: 258 YTDNQGKVQTFKVFEFKTPGVALAMYNTTESIESFAHSSFQ 298
+ V +Y+ E IE A +F+
Sbjct: 145 -----------GSGNGEEGAVDTKLYSRDE-IERIARVAFE 173
>gnl|CDD|177715 PLN00096, PLN00096, isocitrate dehydrogenase (NADP+); Provisional.
Length = 393
Score = 67.0 bits (163), Expect = 2e-12
Identities = 44/122 (36%), Positives = 60/122 (49%), Gaps = 5/122 (4%)
Query: 143 YYDLGLPHRDATEDQVTVDAAVAIKKHNVGIKCATITPDEARVKEFKLKKMWLSPNGTIR 202
++DL +RD TEDQV D A + K TITP +VK LKK W SPNG +R
Sbjct: 33 FFDLRAKNRDDTEDQVLRDVIEAGARLKAIFKEPTITPTADQVKRLGLKKAWGSPNGAMR 92
Query: 203 NILGG-TVFREPIICKNIPKIVPGWTNSIVIGRHAHGDQYKATDLIVDKPGKVELVYTDN 261
G T+ R+ I +I + G+ + RHA G +Y A IV K G + +
Sbjct: 93 RGWNGITISRDTI---HIDGVELGYKKPVFFERHAVGGEYSAGYKIVGK-GTLVTTFVPE 148
Query: 262 QG 263
+G
Sbjct: 149 EG 150
>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein
Serine/Threonine Kinase, p21-activated kinase 1.
Serine/threonine kinases (STKs), p21-activated kinase
(PAK) 1, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The PAK
subfamily is part of a larger superfamily that includes
the catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. PAKs are Rho family GTPase-regulated kinases
that serve as important mediators in the function of
Cdc42 (cell division cycle 42) and Rac. PAKs from higher
eukaryotes are classified into two groups (I and II),
according to their biochemical and structural features.
PAK1 belongs to group I. Group I PAKs contain a PBD
(p21-binding domain) overlapping with an AID
(autoinhibitory domain), a C-terminal catalytic domain,
SH3 binding sites and a non-classical SH3 binding site
for PIX (PAK-interacting exchange factor). PAK1 is
important in the regulation of many cellular processes
including cytoskeletal dynamics, cell motility, growth,
and proliferation. Although PAK1 has been regarded
mainly as a cytosolic protein, recent reports indicate
that PAK1 also exists in significant amounts in the
nucleus, where it is involved in transcription
modulation and in cell cycle regulatory events. PAK1 is
also involved in transformation and tumorigenesis. Its
overexpression, hyperactivation and increased nuclear
accumulation is correlated to breast cancer invasiveness
and progression. Nuclear accumulation is also linked to
tamoxifen resistance in breast cancer cells.
Length = 296
Score = 33.5 bits (76), Expect = 0.10
Identities = 16/60 (26%), Positives = 27/60 (45%), Gaps = 1/60 (1%)
Query: 150 HRDATEDQVTVDAAVAIKKHNVGIKCATITPDEARVKEFKLKKMWLSPNGTIRNILGGTV 209
HRD D + + ++K + G CA ITP++++ W++P R G V
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGF-CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197
>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein
Serine/Threonine Kinase, p21-activated kinase 2.
Serine/threonine kinases (STKs), p21-activated kinase
(PAK) 2, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The PAK
subfamily is part of a larger superfamily that includes
the catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. PAKs are Rho family GTPase-regulated kinases
that serve as important mediators in the function of
Cdc42 (cell division cycle 42) and Rac. PAKs from higher
eukaryotes are classified into two groups (I and II),
according to their biochemical and structural features.
PAK2 belongs to group I. Group I PAKs contain a PBD
(p21-binding domain) overlapping with an AID
(autoinhibitory domain), a C-terminal catalytic domain,
SH3 binding sites and a non-classical SH3 binding site
for PIX (PAK-interacting exchange factor). PAK2 plays a
role in pro-apoptotic signaling. It is cleaved and
activated by caspases leading to morphological changes
during apoptosis. PAK2 is also activated in response to
a variety of stresses including DNA damage,
hyperosmolarity, serum starvation, and contact
inhibition, and may play a role in coordinating the
stress response. PAK2 also contributes to cancer cell
invasion through a mechanism distinct from that of PAK1.
Length = 296
Score = 32.0 bits (72), Expect = 0.37
Identities = 17/60 (28%), Positives = 27/60 (45%), Gaps = 1/60 (1%)
Query: 150 HRDATEDQVTVDAAVAIKKHNVGIKCATITPDEARVKEFKLKKMWLSPNGTIRNILGGTV 209
HRD D V + ++K + G CA ITP++++ W++P R G V
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGF-CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
>gnl|CDD|179150 PRK00876, nadE, NAD synthetase; Reviewed.
Length = 326
Score = 31.8 bits (73), Expect = 0.39
Identities = 13/42 (30%), Positives = 20/42 (47%)
Query: 211 REPIICKNIPKIVPGWTNSIVIGRHAHGDQYKATDLIVDKPG 252
R+ I + +P+ PGW + IV+ GD L+V P
Sbjct: 109 RDEAIRRVVPEYGPGWKSKIVLPNLLDGDGLNVFSLVVQDPD 150
>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein
Serine/Threonine Kinase, p21-activated kinase 3.
Serine/threonine kinases (STKs), p21-activated kinase
(PAK) 3, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The PAK
subfamily is part of a larger superfamily that includes
the catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. PAKs are Rho family GTPase-regulated kinases
that serve as important mediators in the function of
Cdc42 (cell division cycle 42) and Rac. PAKs from higher
eukaryotes are classified into two groups (I and II),
according to their biochemical and structural features.
PAK3 belongs to group I. Group I PAKs contain a PBD
(p21-binding domain) overlapping with an AID
(autoinhibitory domain), a C-terminal catalytic domain,
SH3 binding sites and a non-classical SH3 binding site
for PIX (PAK-interacting exchange factor). PAK3 is
highly expressed in the brain. It is implicated in
neuronal plasticity, synapse formation, dendritic spine
morphogenesis, cell cycle progression, neuronal
migration, and apoptosis. Inactivating mutations in the
PAK3 gene cause X-linked non-syndromic mental
retardation, the severity of which depends on the site
of the mutation.
Length = 297
Score = 31.2 bits (70), Expect = 0.58
Identities = 16/60 (26%), Positives = 27/60 (45%), Gaps = 1/60 (1%)
Query: 150 HRDATEDQVTVDAAVAIKKHNVGIKCATITPDEARVKEFKLKKMWLSPNGTIRNILGGTV 209
HRD D + + ++K + G CA ITP++++ W++P R G V
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGF-CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
>gnl|CDD|179615 PRK03634, PRK03634, rhamnulose-1-phosphate aldolase; Provisional.
Length = 274
Score = 29.2 bits (66), Expect = 2.5
Identities = 10/29 (34%), Positives = 16/29 (55%)
Query: 37 IVAKNPVVEMDGDEMTRIIWENIKEKLIF 65
++A V+E+D TR +WE E L+
Sbjct: 147 LIALTYVLELDEAVFTRTLWEMSTECLVV 175
>gnl|CDD|236209 PRK08265, PRK08265, short chain dehydrogenase; Provisional.
Length = 261
Score = 28.8 bits (65), Expect = 3.1
Identities = 10/20 (50%), Positives = 13/20 (65%)
Query: 224 PGWTNSIVIGRHAHGDQYKA 243
PGWT S V+ + GD+ KA
Sbjct: 180 PGWTWSRVMDELSGGDRAKA 199
>gnl|CDD|222666 pfam14307, Glyco_tran_WbsX, Glycosyltransferase WbsX. Members of
this family are found in within O-antigen biosynthesis
clusters in Gram negative bacteria, where they are
predicted to function as glycosyltransferases.
Length = 345
Score = 28.3 bits (64), Expect = 4.6
Identities = 23/117 (19%), Positives = 34/117 (29%), Gaps = 30/117 (25%)
Query: 119 KHGFM--YFMASRIQIISNIIDVECLYYDLGLPHRDATEDQVTVDAAVAIKKHNVGIKCA 176
+ G Y +A +I++ + DLG DAAV H K
Sbjct: 186 EAGLPGLYLVA----VINSFEEEYKDPRDLGF------------DAAVEFPPHYA-NKGK 228
Query: 177 TITPDEARVKEFKLKKMW----LSPNGTIRNILGGTVFREPIICKNIPKIVPGWTNS 229
+ + KK + + IL P P PGW N+
Sbjct: 229 KL---PNKYVRLLNKKFGKGDVYDYDKVVEYILNRPAPDYPYY----PGAFPGWDNT 278
>gnl|CDD|220011 pfam08770, SoxZ, Sulphur oxidation protein SoxZ. SoxZ forms an
anti parallel beta structure and forms a complex with
SoxY. Sulphur oxidation occurs at the thiol of a
conserved cysteine residue of the SoxY subunit.
Length = 98
Score = 26.4 bits (59), Expect = 8.0
Identities = 6/20 (30%), Positives = 12/20 (60%)
Query: 248 VDKPGKVELVYTDNQGKVQT 267
K G +++ +TDN+G+
Sbjct: 74 GAKAGTLKVTWTDNKGESFE 93
>gnl|CDD|226595 COG4110, COG4110, Uncharacterized protein involved in stress
response [General function prediction only].
Length = 200
Score = 27.1 bits (60), Expect = 8.9
Identities = 18/71 (25%), Positives = 29/71 (40%), Gaps = 21/71 (29%)
Query: 19 IDTNVSFFFVFQDATDSRIVA---------KNPVVEMDGDEMT------------RIIWE 57
ID ++ F D + I A P V++DGD+ T W+
Sbjct: 50 IDLDLGAFVELNDGSKGVIQALGNAFGSYRDEPYVQLDGDDRTGDVSDGEWLHINGREWK 109
Query: 58 NIKEKLIFPYV 68
+IKE LI+ ++
Sbjct: 110 HIKEVLIYAFI 120
>gnl|CDD|100019 cd02190, epsilon_tubulin, The tubulin superfamily includes five
distinct families, the alpha-, beta-, gamma-, delta-,
and epsilon-tubulins and a sixth family (zeta-tubulin)
which is present only in kinetoplastid protozoa. The
epsilon-tubulins which are widespread but not ubiquitous
among eukaryotes play a role in basal body/centriole
morphogenesis.
Length = 379
Score = 27.7 bits (62), Expect = 9.4
Identities = 16/52 (30%), Positives = 25/52 (48%), Gaps = 3/52 (5%)
Query: 199 GTIRNILGGTVFREPIICKNIPKIVPGWTNSIVIGRHAHGDQYKATDLIVDK 250
G + IL G + R+ + V G N+ +G H +G QY D I++K
Sbjct: 40 GVVNEILKGPL-RDLFDETQLVTDVSGAGNNWAVGYHQYGHQYI--DSILEK 88
Database: CDD.v3.10
Posted date: Mar 20, 2013 7:55 AM
Number of letters in database: 10,937,602
Number of sequences in database: 44,354
Lambda K H
0.324 0.139 0.420
Gapped
Lambda K H
0.267 0.0818 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Sequences: 44354
Number of Hits to DB: 15,540,927
Number of extensions: 1503210
Number of successful extensions: 1494
Number of sequences better than 10.0: 1
Number of HSP's gapped: 1483
Number of HSP's successfully gapped: 36
Length of query: 303
Length of database: 10,937,602
Length adjustment: 96
Effective length of query: 207
Effective length of database: 6,679,618
Effective search space: 1382680926
Effective search space used: 1382680926
Neighboring words threshold: 11
Window for multiple hits: 40
X1: 15 ( 7.0 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 40 (21.5 bits)
S2: 59 (26.3 bits)